4115 Stock Overview
Sunder Biomedical Tech. Co., Ltd. engages in the manufacture and sale of medical devices.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Sunder Biomedical Tech. Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$13.25 |
| 52 Week High | NT$18.10 |
| 52 Week Low | NT$11.45 |
| Beta | 0 |
| 1 Month Change | 13.25% |
| 3 Month Change | -8.30% |
| 1 Year Change | -25.56% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -28.38% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4115 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | -2.6% | 4.6% | 5.5% |
| 1Y | -25.6% | 5.4% | 29.7% |
Return vs Industry: 4115 underperformed the TW Medical Equipment industry which returned 5.4% over the past year.
Return vs Market: 4115 underperformed the TW Market which returned 29.7% over the past year.
Price Volatility
| 4115 volatility | |
|---|---|
| 4115 Average Weekly Movement | 6.1% |
| Medical Equipment Industry Average Movement | 4.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 4115 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4115's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | n/a | www.sunder.com.tw |
Sunder Biomedical Tech. Co., Ltd. engages in the manufacture and sale of medical devices. It offers protective goggles, melt blown nonwoven fabrics and masks, suction irrigation sets, smoke filters, endo bags, blood line sets for hemodialysis, A.V. Fistula needle sets, I.V. administration sets, extension tube, volume control I.V. administration sets, surgical tubing sets, and transducer protector, as well as PVC compounds for medical applications.
Sunder Biomedical Tech. Co., Ltd. Fundamentals Summary
| 4115 fundamental statistics | |
|---|---|
| Market cap | NT$795.00m |
| Earnings (TTM) | NT$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 4115 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4115 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$0 |
| Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 4115 perform over the long term?
See historical performance and comparison